Purpose | AGM Date | Announcement Date |
---|---|---|
AGM | 8 Aug 2025 | 11 Jul 2025 |
The Board in its meeting approved the Annual General Meeting related Matters and fixed August 8 2025 as the Annual General Meeting date. Newspaper Publication for AGM intimation (As Per BSE Announcement Dated on 14.07.2025) The 33rd Annual General Meeting of the Company is proposed to be held on August 8, 2025 through audio visual means to transact the business as stated in the notice. (As Per BSE Announcement Dated on: 16.07.2025) Please find attached newspaper publication for the Annual General Meeting Notice (As per BSE Announcement Dated on 17.07.2025) Attached is the copy of Newspaper Publication of addendum to the notice of 33rd Annual General Meeting. (As per BSE Announcement Dated on 28/07/2025) | ||
AGM | 24 Sep 2024 | 19 Aug 2024 |
AGM 24/09/2024 Kindly find enclosed the proceedings of 32nd AGM of the Company held on September 24, 2024 (As Per BSE Announcement dated on 24.09.2024) Kindly find enclosed the Voting results and scrutinizer report of e-voting held at the 32nd AGM (As per BSE Announcement Dated on 25/09/2024) |
The inspection by the USFDA had taken place between April 16 and 24. After the visit, the company disclosed one observation under Form 483.
The block deal has been launched at a floor price of ₹249.95 per share, signaling a strategic partial exit by the investor.
Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets
The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.